tirzepatide and kidneys improves kidney outcomes in T2DM with increased CV risk Cardiorenal benefits of tirzepatide. By

Patients should discuss alcohol use with their healthcare provider, as individual risk factors vary

Advances in bariatric surgery and weight-loss medications have made weight management accessible to more adults

Gout There are some limited studies in patients with gout, some reporting a possible flare of gout when therapy with GLP1 is started, mostly due to rapid weight loss and dehydration that may precipitate gout attacks

This is a common draw for starting doses at higher concentrations

Both Novo Nordisk and Eli Lilly have announced price reductions through direct-to-consumer programs and the TrumpRx website established in late 2025